U.S. markets closed
  • S&P Futures

    4,227.00
    +1.75 (+0.04%)
     
  • Dow Futures

    34,713.00
    +27.00 (+0.08%)
     
  • Nasdaq Futures

    13,716.00
    +6.25 (+0.05%)
     
  • Russell 2000 Futures

    2,269.60
    +1.70 (+0.07%)
     
  • Crude Oil

    65.48
    +0.58 (+0.89%)
     
  • Gold

    1,833.90
    +2.60 (+0.14%)
     
  • Silver

    27.66
    +0.18 (+0.65%)
     
  • EUR/USD

    1.2174
    +0.0106 (+0.88%)
     
  • 10-Yr Bond

    1.5770
    +0.0160 (+1.02%)
     
  • Vix

    16.69
    -1.70 (-9.24%)
     
  • GBP/USD

    1.4010
    +0.0117 (+0.84%)
     
  • USD/JPY

    108.5200
    -0.5650 (-0.52%)
     
  • BTC-USD

    58,076.58
    -706.91 (-1.20%)
     
  • CMC Crypto 200

    1,480.07
    +44.29 (+3.08%)
     
  • FTSE 100

    7,129.71
    +53.54 (+0.76%)
     
  • Nikkei 225

    29,357.82
    +26.42 (+0.09%)
     

Company News for May 19, 2020

Zacks Equity Research
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Shares of Tesla Inc. TSLA rose 1.8% following the news that the company received permission from the local authority to resume operation in its Fremont auto plant.

  • Shares of Apple Inc. AAPL gained 2.4% following the company's decision to reopen 25 stores this week.

  • Vir Biotechnology Inc.'s VIR shares jumped 32.1% after the company identified and characterized a potential therapeutic COVID-19 antibody.

  • Eldorado Resorts Inc.'s  ERI shares soared 19.8% following the company's decision to reopen three Louisiana casinos.
     


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Apple Inc. (AAPL) : Free Stock Analysis Report
 
Tesla, Inc. (TSLA) : Free Stock Analysis Report
 
Eldorado Resorts, Inc. (ERI) : Free Stock Analysis Report
 
Vir Biotechnology, Inc. (VIR) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research